Skip to Main Content

Paper Details

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer.
Oncogene
130
2019
CRISPR, EGFR, EGFR mutant, EGFR mutant cancers, EGFR mutant drug-tolerant cells, EGFR mutant non-small cell lung cancer, EGFR-mutated NSCLCs, EGFRT790M, EGFRT790M mutation, FGFR, FGFR1, NSCLC, cancers, drug-tolerant persister cells, epidermal growth factor receptor, fibroblast, growth factor receptor 1, mesenchymal, mesenchymal cell lines, non-small-cell lung cancer, patients, persister cells, persister populations, resistant cells, tyrosine, tyrosine kinase, vitro models
Author NameAffiliation
Yotam DrierMassachusetts General Hospital (MGH) Cancer Center
Joshua M KornNovartis Institutes for Biomedical Research
Cyril H BenesMassachusetts General Hospital (MGH) Cancer Center
Cyril H BenesHarvard Medical School
Peter S HammermanNovartis Institutes for Biomedical Research
Peter S HammermanNovartis Institutes for Biomedical Research
Lecia V SequistMassachusetts General Hospital (MGH) Cancer Center
Lecia V SequistHarvard Medical School
Jordi BarretinaNovartis Institutes for Biomedical Research
  • 1 - 9

Datasets

Release 1.2